Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare ...

ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº ...

NDAQ:PCRX) Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization ...

ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioverao ...

Clearside developed and gained approval for its first product, XIPERE ® (triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the U.S. through a commercial ...

Other revenue, including sales of bupivacaine liposome injectable suspension and ... in patients who are hypersensitive to triamcinolone acetonide, corticosteroids or any components of the product.

Other revenue, including sales of bupivacaine liposome injectable suspension and royalties ... ZILRETTA employs proprietary microsphere technology combining triamcinolone acetonide-a commonly ...